Wall Street Titan
Wall Street Titan
Send Message
Wall Street Titan
Stop FollowingWall Street Titan
-
Wall Street Titan
LNKD starting to break down, ahead of $500,000,000 secondary that should happen before insider lock-up expires on 11/20. - View all 0 replies
-
Wall Street Titan
Athersys (ATHX) CEO purchasing shares. Clinical results due this QTR. Stem cell sector in play with CEPH $2B commitment to Mesoblast. BUY - View all 0 replies


